FDA Recall Terminated

Dimension Vista B2-Microglobulin Flex Reagent Cartridge (B2MIC); Product Usage: The B2MIC method is an in vitro diagnostic test for the quantitative measurement of B2-Microglobulin in human serum, heparinized plasma, EDTA plasma and urine on the Dimension Vista System. Measurements of B2-Microglobulin aid in the diagnosis of active rheumatoid arthritis and kidney disease.

Recall: Z-2450-2015 · Initiated July 23, 2015

Recall

Recall Number
Z-2450-2015
Event Number
71831
Firm
Siemens Healthcare Diagnostics, Inc.
FEI Number
2517506
Product Code
JZG
Status
Terminated
Root Cause
Environmental control
Initiated
July 23, 2015
Posted
August 22, 2015
Terminated
March 24, 2017
Address
500 Gbc Dr PO BOX 6101, Ms 514, Newark, DE, 19702-2466

Description

Dimension Vista B2-Microglobulin Flex Reagent Cartridge (B2MIC); Product Usage: The B2MIC method is an in vitro diagnostic test for the quantitative measurement of B2-Microglobulin in human serum, heparinized plasma, EDTA plasma and urine on the Dimension Vista System. Measurements of B2-Microglobulin aid in the diagnosis of active rheumatoid arthritis and kidney disease.

Reason

customers are receiving a high number of Abnormal Assay Errors or are not able to calibrate B2MIC when using Flex reagent cartridge B2MIC various lots. In failure mode, there is the potential for falsely depressed beta2-Microglobulin results on the Dimension Vista system due to assay reagent contamination.

Action

Siemens sent an Urgent Medical Device Correction letter dated July 2015 to all affected customers. The letter identified the affected product, problem, risk to health, and actions to be taken by customers. For questions contact your Customer Care Center - Technical Solutions at 1-800-441-9250 or your local Siemens technical support representative.

Distribution

US Nationwide Distribution in the states of TN, AZ, CT, Fl, CA, NY and WI

Quantity

Total 1655 units